Design of Some New Potent Beta-secretase Inhibitors Based on QSAR and Molecular Modeling Study on a Series of Hydroxyethylamine Derivatives

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 3, 2013-01 ,pp. : 253-265

Bentham Science Publishers

Access to resources Recommend Favorite

Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1433-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-01 ,pp. : 452-459

Bentham Science Publishers

Access to resources Recommend Favorite

Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 391-401

Bentham Science Publishers

Access to resources Recommend Favorite

Beta-Secretase: Structure, Function, and Evolution

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-01 ,pp. : 278-294

Bentham Science Publishers

Access to resources Recommend Favorite